Buy Pharma As A Bucket, Be Stock-specific In Auto: Sudip Bandyopadhyay, Inditrade Capital

To see your saved stories, click on link hightlighted in bold. It may languish in and around these levels for some time till at least some of these issues -- rupee, oil prices and stability in trade issues -- start getting cleared up. The larger issue is the vehicle scrappage policy which is buypharma circulated and which is being talked about. Get instant notifications from Buypharma Times Allow Not now You can switch off notifications anytime using browser settings. What do you buypharma could fuel the rise of the markets even further? It happened in the first quarter of the current fiscal. Bullish on two pharma stocks in near term: Three, the growing spectre of a global trade war. Which are the sectors and the stocks that are giving you comfort in this market? What has been worrying the market are the global headwinds. As far as domestic issues are concerned, we are by and large in a favourable territory. For an investor in buypharma volatile market with depreciating currency, pharma definitely is a good bet. However, it is not going to move up sharply in a hurry either. Fill in your details: With the onset of the festive season, things are going to improve further from here. One, the rupee depreciation has been a significant concern for a section of the market which is getting impacted by the depreciation. Sudip Bandyopadhyay, Inditrade Capital. As global headwinds are being compensated to some extent by domestic positive factors, the market is not crashing anytime soon. Elections biggest trigger but after that fundamentals to dominate: The valuation after correction looks attractive and we definitely recommend a buy there. Ravi Sundar Muthukrishnan, Elara Securities. Things are just simmering and a few noises are being made which are bit unsettling. This will alert our moderators to take action Name Reason for reporting: Most of the companies have tried to get their act together, buypharma. Sudip Bandyopadhyay is bullish on corporate banks; Here's why.

My Saved Articles Sign in Buypharma buyppharma. Farm income is expected to increase buypharma with good monsoon, buypharma. It has corrected significantly from where it was and their core business is doing fantastically well. Titan is a fantastic company. Double-digit volume growth should come through with consumption picking up: The valuation looks attractive. Will buupharma displayed Will buyphatma be displayed Will be buypharma. Overall, the market is on tenterhooks. Ashok Buypharma in the commercial vehicle space is working on that and they have the capacity to deliver electronic vehicles as well and that is excellent. Read more on Inditrade Capital Ltd, buypharma. All these global factors are becoming a cause for significant concern. What has been worrying the market are the global headwinds. Sudip Bandyopadhyay, Inditrade Capital. As far as domestic issues are concerned, we are by and large in a favourable territory. However, it is not going to move up sharply in a hurry either. Monsoon has been generally good. This will alert our moderators to take action Name Reason for reporting: Market correction was clearly on the horizon: Most of the companies have tried to get their act together. In the two-wheeler space, Hero MotoCorp is definitely a stand out with the rural market getting a lot of attention as buypharma is an election year. Elections biggest trigger but after that fundamentals to dominate: The commercial vehicle cycle has clearly buyphaema and that ensures that companies like Ashok Leyland continues guypharma outperform the expectations. There has been some announcements in Bajaj regarding their capacity to deliver electrical three-wheelers and for that they will not require any licenses.

What do you think could fuel the rise of the markets even further? Which are the sectors and the stocks that are giving you comfort in this market? Bullish on two pharma stocks in near term: Buypharma, they have started getting a lot of export orders including in double-decker buses where they have the skill sets. They are expecting large sales and they have got the export market working for them. But our strategy has been very clearly to buy a basket of pharma companies so that you avoid the vagaries of buypharma company related regulatory action. Do you believe that we can hold our head above the 10, mark? One, the rupee depreciation has been a significant concern for a section of the market which is getting impacted by the depreciation. The commercial vehicle cycle has clearly turned and that ensures that companies like Ashok Leyland continues to outperform the expectations. The valuation looks attractive. What has been worrying the market are the global headwinds, buypharma. Titan is buypharma fantastic company. All these global factors are becoming a cause for significant concern. Could buypharma like the currency and improvement in US business prove to buypharma tailwinds for the sector as a whole? To see your saved stories, click on link hightlighted in bold. Get instant notifications from Economic Times Allow Not now. There has been some announcements in Bajaj regarding their capacity to deliver electrical three-wheelers and for that they will not require any licenses. For an investor in a volatile market with depreciating currency, pharma definitely is a good bet. Overall, the market is on tenterhooks. Drag according to your convenience. As far as domestic issues are concerned, we are by and large in a favourable territory. Expect sharp recovery in index earnings growth next year: NIFTY 50 10, This will alert our moderators to take action Name Reason for reporting: Two, when global oil price was moving up sharply, it was a matter of huge concern for most of us including the economy as a whole.

Drag according to your convenience. As global headwinds are being compensated to some extent by domestic positive factors, the market is not crashing anytime soon. Buypahrma the onset of the festive season, things are going to improve further from here. It has corrected significantly from where it was and their core business is doing fantastically well. It has not been resolved. The valuation after correction looks attractive and we definitely recommend a buy there. The spectacles and watch businesses have started performing well. Do you believe that we can hold our head above the 10, mark? One, the rupee depreciation has been a significant concern for a section of the market which is getting impacted by the depreciation. Find this comment offensive? Double-digit volume growth should come through with consumption picking up: Market correction was clearly on the horizon: Hero with its outstanding reach in the rural market should benefit and buypahrma should be the outperformers amongst the two-wheeler companies. For an investor in a volatile market with depreciating currency, buypharma, pharma definitely is a good bet. Yes, there may be sporadic action here and there from US FDA but by and large things have buyphsrma significantly from what buypharma was couple of years back. Will be displayed Will not be displayed Will be displayed. Also, they have started getting a lot of export orders including in double-decker buses where they have the skill sets. Two, when global oil price was moving up sharply, it was a matter of huge concern for most buypharma us including the economy as a whole. Foul language Slanderous Inciting hatred against a certain community Others. You talked about environment-friendly vehicles buypharma electric vehicles. Titan is a fantastic company.

Buypharma

Your Reason has been Reported to the admin. You talked about environment-friendly vehicles and electric vehicles. Buypharma are the sectors and the stocks that are giving you comfort in this market? In the two-wheeler space, Hero MotoCorp is definitely a stand out with the rural market getting a lot of attention as this is an election year. The commercial vehicle cycle has clearly turned and that ensures that companies like Ashok Leyland continues to outperform the expectations. As you rightly pointed out US business is improving and to a great extent the buypharma action is also behind the industry. Elections biggest trigger but after that fundamentals to dominate: It happened in the first quarter of the current fiscal. Will be displayed Will not be displayed Will be displayed. Fill in your details: This will alert our moderators to take action Name Reason for reporting: Bullish on two pharma stocks in near term: The corporate performance during the first quarter of the current buyphzrma has been excellent, buypharma, much beyond expectations and that has kind of fuelled the rally which we saw over the last one, one-and-a-half months. We have buypyarma particularly bullish on the commercial vehicle segment and Ashok Leyland is one company on which we have been recommending a buy. Monsoon has been generally good.

Pankaj Murarka, buypharma, Renaissance Investment. There has been buypharma announcements in Bajaj regarding their capacity to deliver electrical three-wheelers and for that they will not require any licenses. The larger issue is the vehicle scrappage policy which is being circulated and which is being talked about. Bullish on two pharma stocks in near term: Monsoon has been generally good. Which are the sectors and the stocks that are giving you comfort in this market? Get instant notifications from Economic Times Allow Not now You can switch off notifications anytime using browser settings. Overall, the market is bbuypharma buypharma. Will be displayed Will not be buypharma Will be displayed. NIFTY 50 10, As you rightly pointed out US business is improving and to a great extent the regulatory action is also behind the industry. They came up with excellent results. Things are just simmering and a few noises are being made which are bit unsettling. Read more on Inditrade Capital Ltd. But our strategy has been very clearly to buypharma a basket of pharma companies so that you avoid the vagaries of individual bypharma related regulatory action, buypharma. We have been positive for some time on the pharma sector and this is one sector where investors should start moving money definitely. Yes, there may be sporadic action here and there from US FDA but by and large things have improved significantly from what it was couple of years back. All these global factors are becoming a cause for significant concern. The spread also has been decent by and large. It is a destabilising factor. What do you think could buypharma the rise of buyhparma markets even further? Expect sharp recovery in index earnings growth next year: It has not performed as a sector for quite some time.

Pankaj Murarka, Renaissance Investment. It happened in the first quarter of the current fiscal. The spectacles and watch businesses have started performing well. The larger issue is the vehicle scrappage policy which is being circulated and which is being talked buypharma. Monsoon has been generally good. Hero with its outstanding reach in the rural market should benefit and they should be the outperformers amongst the two-wheeler companies. The market is not crashing anytime soon. Your Reason buypjarma buypharma Reported to the admin. Bullish buypharma two pharma stocks in near term: My Saved Articles Sign in Sign up. Three, the growing spectre of a global trade war. Expect sharp recovery in index earnings growth next year: Two, buypharma, when global oil price was moving up sharply, it was a matter of huge concern for most of buyypharma including the economy as a whole. As far as domestic issues are concerned, we are by and large in a favourable territory. Foul language Slanderous Inciting hatred against a certain community Others. Sudip Bandyopadhyay is bullish on corporate banks; Here's why.

We have been positive for some time on the pharma sector and this is one sector where investors should start moving money definitely. Ravi Sundar Muthukrishnan, Elara Securities. But our strategy has been very clearly to buy a basket of pharma companies so that you avoid the vagaries of individual company related regulatory action. It is a matter of time before the vehicle scrappage policy comes and that policy is going to help companies like Ashok Leyland in a big way. Double-digit volume growth should come through with consumption picking up: With the onset of the festive season, things are going to improve further from here. As global headwinds are being compensated to some extent by domestic positive factors, the market is not crashing anytime soon. Read more on Inditrade Capital Ltd. Get instant notifications from Economic Times Allow Not now You can switch off notifications anytime using browser settings. Fill in your details: You talked about environment-friendly vehicles and electric vehicles. Titan is a fantastic company. The valuation after correction looks attractive and we definitely recommend a buy there. There has been some announcements in Bajaj regarding their capacity to deliver electrical three-wheelers and for that they will not require any licenses. Also, they have started getting a lot of export orders including in double-decker buses where they have the skill sets. Never miss a great news story! The market is not crashing anytime soon. We are positive as far as Q3 is concerned: Market correction was clearly on the horizon: There are always some uncertainties with pharma companies because of the regulatory action and the consequences thereof, like we have seen in Sun Pharma today. Drag according to your convenience. What do you think could fuel the rise of the markets even further? It is a destabilising factor.

buypharma

Expect sharp recovery in index earnings growth next year: We have been positive for some time on the pharma sector and this is one sector where investors should start moving money definitely. There are always some uncertainties with pharma companies because of the regulatory action and the consequences thereof, like we have seen in Sun Pharma today. My Saved Articles Sign in Sign up. Bullish on two pharma stocks in near term: Sudip Bandyopadhyay, Inditrade Capital. Farm income is expected to increase significantly with good monsoon. It happened in the first quarter of the current fiscal. Market does not have trigger to break out of range: Will be displayed Will not be displayed Will be displayed. Titan is a fantastic company. As you rightly pointed out US business is improving and to a great extent the regulatory action is also behind the industry. Do you believe that we can hold our head above the 10, mark? The valuation looks attractive. Your Reason has been Reported to the admin. To see your saved stories, click on link hightlighted in bold. For an investor in a volatile market with depreciating currency, pharma definitely is a good bet. It has corrected significantly from where it was and their core business is doing fantastically well. It is a matter of time before the vehicle scrappage policy comes and that policy is going to help companies like Ashok Leyland in a big way. As far as domestic issues are concerned, we are by and large in a favourable territory. What is your assessment of the pharma pack as a whole? How are you looking at the auto space? Monsoon has been generally good. Do you believe that we can hold our head above the 10, mark? Which are the sectors and the stocks that are giving you comfort in this market? However, it is not going to buypharma up sharply in a hurry either. The spectacles and watch businesses have started performing well. The market is not buypharma anytime soon.

Elections biggest trigger but after that fundamentals to dominate: Farm income is expected to increase significantly with good monsoon. In the two-wheeler space, Hero MotoCorp is definitely a stand out with the rural market getting a lot of attention as this is an election year. What do you think could fuel the rise of the markets even further? Things are just simmering and a few noises are being made which are bit unsettling. Two, when global oil price was moving up sharply, it was a matter of huge concern for most of us including the economy as a whole. The valuation after correction looks attractive and we definitely recommend a buy there. Foul language Slanderous Inciting hatred against a certain community Others. Sudip Bandyopadhyay is bullish on corporate banks; Here's why. Overall, the market is on tenterhooks. The corporate performance during the first quarter of the current fiscal has been excellent, much beyond expectations and that has kind of fuelled the rally which we saw over the last one, one-and-a-half months. It is a good company to buy into but between the two-wheeler companies, we will go for Hero MotoCorp. Bullish on two pharma stocks in near term: You talked about environment-friendly vehicles and electric vehicles. Also, in jewellery business, Titan benefits from impeccable credibility. There has been some announcements in Bajaj regarding their capacity to deliver electrical three-wheelers and for that they will not require any licenses. To see your saved stories, click on link hightlighted in bold. Ravi Sundar Muthukrishnan, Elara Securities. But our strategy has been very clearly to buy a basket of pharma companies so that you avoid the vagaries of individual company related regulatory action. As far as domestic issues are concerned, we are by and large in a favourable territory. It is a matter of time before the vehicle scrappage policy comes and that policy is going to help companies like Ashok Leyland in a big way. NIFTY 50 10, As global headwinds are being compensated to some extent by domestic positive factors, the market is not crashing anytime soon. But the stock has been beaten down in recent past. It is a good company to buy into but between the two-wheeler companies, we will go for Hero MotoCorp. To see buypharma saved stories, click on link hightlighted in bold. Sudip Bandyopadhyay, Inditrade Capital. Also, they have started getting a lot of export orders including in double-decker buses where they have the skill sets. Ravi Sundar Muthukrishnan, Elara Securities. Buypharma, the market is on tenterhooks. Three, the growing spectre of a global trade war.